SEP
ABBV icon

Southland Equity Partners’s AbbVie ABBV Stock Holding History

Southland Equity Partners’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.11M Buy
28,242
+957
+4% +$206K 1.24% 16
2026
Q1 		$5.93M Sell
27,285
-273
-1% -$60.6K 1.16% 19
2025
Q4 		$6.3M Sell
27,558
-746
-3% -$170K 1.24% 18
2025
Q3 		$6.55M Buy
28,304
+121
+0.4% +$24.6K 1.33% 19
2025
Q2 		$5.23M Sell
28,183
-161
-0.6% -$29.9K 1.15% 21
2025
Q1 		$5.94M Sell
28,344
-101
-0.4% -$19.6K 1.38% 17
2024
Q4 		$5.05M Buy
28,445
+3,954
+16% +$727K 1.18% 21
2024
Q3 		$4.84M Buy
24,491
+6,736
+38% +$1.26M 1.18% 19
2024
Q2 		$3.05M Buy
17,755
+10,078
+131% +$1.67M 0.87% 27
2024
Q1 		$1.4M Buy
7,677
+1,481
+24% +$255K 0.39% 48
2023
Q4 		$960K Sell
6,196
-315
-5% -$45.9K 0.3% 55
2023
Q3 		$970K Buy
6,511
+137
+2% +$20.1K 0.33% 50
2023
Q2 		$859K Buy
6,374
+1,864
+41% +$273K 0.29% 55
2023
Q1 		$719K Sell
4,510
-43
-0.9% -$6.57K 0.28% 56
2022
Q4 		$736K Buy
4,553
+464
+11% +$71.1K 0.28% 53
2022
Q3 		$549K Sell
4,089
-188
-4% -$27K 0.27% 63
2022
Q2 		$655K Buy
4,277
+71
+2% +$10.8K 0.3% 59
2022
Q1 		$682K Buy
4,206
+5
+0.1% +$726 0.28% 62
2021
Q4 		$569K Buy
4,201
+92
+2% +$10.9K 0.23% 76
2021
Q3 		$443K Buy
4,109
+153
+4% +$17.5K 0.2% 82
2021
Q2 		$446K Buy
3,956
+5
+0.1% +$563 0.21% 83
2021
Q1 		$428K Buy
3,951
+176
+5% +$18.8K 0.24% 80
2020
Q4 		$404K Buy
+3,775
New +$363K 0.27% 72

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Southland Equity Partners's ABBV Position: Q2 2026 in Review

Southland Equity Partners increased its AbbVie (ABBV) stake by 3.5% in Q2 2026, buying an estimated $206K and bringing the position to 28,242 shares worth $7.11M. The position accounts for 1.24% of the portfolio, ranked #16.

Southland Equity Partners first reported a position in ABBV in Q4 2020 and has held it in 23 quarters since. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Southland Equity Partners held 28,242 shares of AbbVie worth $7.11M as of Q2 2026.
  • Southland Equity Partners bought 957 AbbVie shares in Q2 2026, an estimated $206K.
  • AbbVie made up 1.24% of Southland Equity Partners's portfolio in Q2 2026, its #16 holding.
  • Southland Equity Partners first reported a position in AbbVie in Q4 2020 and has held it in 23 quarters since.
  • 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Southland Equity Partners's 13F filing for Q2 2026, filed 13 Jul 2026.